Gammacell-220 Excel Refurbished Research Irradiator
Gammacell-220 Excel Refurbished Research Irradiator
批准号:
7046980
负责人:
DAVID H WALKER
金额:
$35.48万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2007-09-30
中文摘要
描述(由申请人提供):在过去的二十年里,德克萨斯大学加尔维斯顿分校(UTMB)根据NIAID为这些病原体开发对策的使命,建立了一个主要的传染病研究项目,专注于新出现的感染和生物防御病原体。这一成功在很大程度上要归功于一大批世界级的研究人员和独特的实验室设施。2003年,UTMB是唯一获得NIAID拨款的学术机构,建立了生物防御和新发传染病研究地区卓越中心和国家生物遏制实验室(NBL),以提供更高的遏制实验室空间。此外,在NIAID的部分支持下,2003年开设了一个生物安全4级(BSL4)实验室(并于2004年投入使用),这是北美大学校园内的第一个此类实验室。这些设施提供了增加整体研究努力的机会,包括对世界上最危险的病原体进行研究的能力。NIAID研究任务范围内的一个关键要求是与区域和国家研究人员共享这些设施,并为只能在这些高度封闭的设施中进行的研究提供支持服务。可靠的生物安全和生物安全方法对于共享和安全使用高度危险的制剂至关重要。因此,总体目标是采购一台Gammacell 220 Excel翻新的研究型辐照器,以提供最具重复性和可控性的方法来灭活这些危险物质,同时保持其生物特性。使用这种仪器的一个例子是灭活裂谷热病毒,以便可以在BSL4实验室外安全地进行基因组和蛋白质组分析。该辐照器将可供NIH支持的UTMB调查人员以及NIH支持的区域和国家调查人员使用。当NBL在2008年完工时,该设施的研究人员也将可以使用辐照器。描述了一个具有代表性的用户小组,其中有21个资助拨款,包括14个主要用户(其中12个是由NIH资助的)和7个次要用户,代表了涉及UTMB几个部门的多学科研究项目。必须指出的是,随着BSL4实验室使用量的增加和NBL的完成,拟议的伽马辐照器的使用量将急剧增加。该辐射器将在一个咨询监督委员会的监督下进行维护和操作,作为UTMB生物防御和新发传染病中心的核心设施。每年的维护费将向PIS收取,并通过BSL4服务中心进行管理。该辐照器将显著提高调查人员安全和更有效地进行研究的能力,并保护社区免受与这些危及生命的病原体工作有关的任何威胁。
英文摘要
DESCRIPTION (provided by applicant): Over the past two decades, the University of Texas Medical Branch at Galveston (UTMB) has built a premier infectious disease research program focused on emerging infections and biodefense pathogens in accordance with the NIAID's mission to develop countermeasures for these agents. This success is largely due to a critical mass of world-class researchers and the availability of unique laboratory facilities. In 2003, UTMB was the only academic institution awarded NIAID grants to establish both a Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research and a National Biocontainment Laboratory (NBL) to provide more high containment laboratory space. In addition, with partial support from the NIAID, a toiosafety level 4 (BSL4) laboratory was opened in 2003 (and became operational in 2004) as the first laboratory of its type on a university campus in North America. These facilities provide an opportunity to increase overall research efforts, including the capability to conduct studies on the world's most dangerous pathogens. A critical requirement inherent to the scope of the NIAID's research mission is to share these facilities with regional and national researchers and to provide support services for research that can only be done in these high containment facilities. A reliable biosafety and biosecurity method is essential for sharing and working safely with the highly dangerous agents. Therefore, the overall objective is to procure a Gammacell 220 Excel refurbished research irradiator to provide the most reproducible and controlled method to inactivate these dangerous agents while at the same time preserving their biological properties. An example of use of this instrument will be to inactivate Rift Valley fever virus such that genomic and proteomics analysis can be safely performed outside the BSL4 laboratory. The irradiator will be available for use by NIH-supported UTMB investigators, as well as NIH-supported regional and national investigators. When the NBL is completed in 2008, researchers from that facility will also have access to the irradiator. A representative users' group with 21 funded grants are described, including 14 major (12 of which are NIH- funded) and 7 minor users representing multidisciplinary research projects involving several departments at UTMB. It is important to note that usage of the proposed gamma irradiator will drastically increase as usage of the BSL4 laboratory increases and with the completion of the NBL. The irradiator will be maintained and operated under an advisory oversight committee as a core facility in the Center for Biodefense and Emerging Infectious Diseases at UTMB. Yearly maintenance fees will be charged to Pis and administered through the BSL4 Service Center. The irradiator will significantly enhance the ability of investigators to conduct research safely and more efficiently, as well as protect the community from any threats that may be associated with working with these life-threatening pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8392057
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8377041
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8377034
-
项目类别:
-
资助金额:$58.39万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8377037
-
项目类别:
-
资助金额:$62.07万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8495268
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8233011
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8233007
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8233008
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8042570
-
项目类别:
-
资助金额:$93.69万
-
财政年份:2010
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:7676462
-
项目类别:
-
资助金额:$71.89万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:7676511
-
项目类别:
-
资助金额:$72.83万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:7676456
-
项目类别:
-
资助金额:$72.2万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise
-
批准号:7908303
-
项目类别:
-
资助金额:$93.23万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7716083
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
EXPERIMENTAL INFECTION OF THE MARMOSET WITH LASSA VIRUS
-
批准号:7716110
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER BIVALENT VACCINE EFFICACY IN MARMOSETS
-
批准号:7716131
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7716059
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
WRCE Administrative Core
-
批准号:7649683
-
项目类别:
-
资助金额:$60.47万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7562433
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7562462
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位: